Aesthetic Outcome of Intra-dermal Versus Transcutaneous Purse-string Closure
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Jun 3, 2024
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The purse-string closure is a versatile technique that utilizes circumferential tissue advancement for partial or complete closure of circular cutaneous surgical defects. First reported in the 1950s for closure of a malar defect, the purse-string closure is now routinely used for umbilical, urethral, and breast defects as well as for cutaneous surgical defects either alone or in conjunction with top sutures, local flaps, or grafts.
Though the purse-string closure was initially described with circumferentially placed intradermal sutures, various modifications to this technique have been pub...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Able to give informed consent themselves
- • Patient scheduled for cutaneous surgical procedure on the head, neck, trunk, or extremities with predicted purse-string closure.
- • Willing to return for follow up visit
- Exclusion Criteria:
- • Incarceration
- • Under 18 years of age
- • Pregnant Women
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Daniel Eisen, MD
Principal Investigator
University of California, Davis - Dermatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported